<?xml version="1.0" encoding="UTF-8"?>
<p>CUPRAC, FRAP, and ORAC assays were performed to determine whether DIBEt is capable to donate electrons and establish that DIBEt has a strong reducing power potential in a dose-dependent manner (
 <xref ref-type="fig" rid="antioxidants-09-01099-f003">Figure 3</xref>C; 
 <xref ref-type="app" rid="app1-antioxidants-09-01099">Supplementary Figure S7</xref>). At 10 µg/mL, DIBEt showed 34.52 ± 0.37 and 81.37 ± 0.57 µM ascorbic acid-equivalent reducing power for CUPRAC and FRAP assays, respectively. Other extracts showed ascorbic acid-equivalent reducing power activities in the following order: DIBE (30.64 ± 0.58 µM) &gt; DIBW (24.51 ± 1.13 µM) &gt; DIBC (11.85 ± 2.03 µM) &gt; DIBH (4.22 ± 0.28 µM) and DIBE (21.08 ± 1.25 µM) &gt; DIBW (19.72 ± 0.80 µM) &gt; DIBC (6.80 ± 0.89 µM) &gt; DIBH (3.30 ± 1.57 µM) for CUPRAC and FRAP assays, respectively. DIBEt showed 9.43 ± 1.97 µM Trolox-equivalent antioxidant capacity at 10 µg/mL in the ORAC assay. Other extracts showed Trolox-equivalent antioxidant capacity in the following order: DIBE (7.87 ± 0.04 µM) &gt; DIBW (5.55 ± 0.27 µM) &gt; DIBC (3.10 ± 0.20 µM) &gt; DIBH (2.74 ± 0.13 µM). Based on these interpretations, DIBEt has a very strong potential to donate/transfer hydrogen/electrons to oxidants to neutralize them.
</p>
